imValv is a leading startup company in treating and managing glaucoma with cutting -edge patented technology combination of intelligent micromachines, internet of things and Big Data. Better treatment, patient monitoring, less cost, avoiding retreatment, and mini mally-invasiveness management avoiding cumbersome lifetime conventional treatment of medical drops and big or passive valves and shunts. We hope to capture a global market valued at USD 1B and to prevent blindness in +70M.
| Website | https://twitter.com/imvalv |
| Employees | 2 (1 on RocketReach) |
| Founded | 2017 |
| Phone | +54 342 451-1594 |
| Industry | Nanotechnology Research |
| Keywords | Glaucoma Management, Glaucoma Treatment, Internet Of Things Iot, Patented Technology, Big Data Analytics, Patient Monitoring, Cost Effective Healthcare, Ophthalmic Devices, Medical Technology, Eye Care, Healthcare Technology, Precision Medicine, Digital Health, Medical Sensors, Data Driven Healthcare, Remote Patient Monitoring, Innovative Medical Solutions |
Looking for a particular iMVALV employee's phone or email?
iMVALV Questions
Fabio Guarnieri is the CEO of iMVALV.
1 people are employed at iMVALV.
Top iMVALV Employees
-
Fabio Guarnieri
Chief Executive Officer at iMVALV
Paraná, Entre Ríos Province, AR1
G2Crowd Trusted
300K+
Plugin Users
